AstraZeneca should face new trial in Nexium case, drug buyers tell appeals court
An appeals court should reopen a so-called pay-for-delay lawsuit over AstraZeneca's alleged efforts to thwart generic competition to its heartburn drug Nexium, drug buyers argued, saying the trial judge stopped a...To view the full article, register now.
Already a subscriber? Click here to view full article